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ABSTRACT 
Abstract of the thesis entitled "EFFECT OF VITAMIN D ON RIBONUCLEIC 
ACID SYNTHESIS IN BONE" submitted by Sue Ann Shelley in partial fulfill-
ment of the requirements for the degree of Master of Science, June, 1971. 
The effect of vitamin D on the incorporation of 3H-uridine into 
RNA of rat bone cells was studied using an in vitro system. Rachitic 
rats were treated with 5,000 I.U. of vitamin n3 or with the vehicle 
only. In some experiments each rat received 100 µg of actinomycin D 
before treatment with vitamin D or vehicle. Five hours after the 
administration of the vitamin or vehicle the rats were sacrificed and 
were dissected out, washed and incubated in medium containing 1 µCi/ml 
of 3H-uridine for 4 hours. After incubation the bone fragments were 
washed repeatedly and the bone cells isolated. 
In some experiments RNA was extracted from the bone cells with 
phenol-sodium dodecyl sulfate and the specific activity of the RNA 
determined. In other experiments the RNA was separated into two. 
0 
fractions by sequential treatment with phenol-SDS at 45°c and 65 C. 
The specific activities of both fractions of RNA were then determined • 
. Comparison of the specj:fic activities of the RNAs from vitamin D3 
treated and from control rats was used as the basis to determine the 
effect of vitamin.D3 , and vitamin n3 following actinomycin D treatment, 
on the incorpor~tion of 3n-uridine into RNA.s of rat bone cells. 
Treatment with vitamin D3 increased the incorporation of 3H-uridine 
into the cytoplasmic RNA of rachitic bone.cells in this in vitro system. 
Prior treatment of the animals with actinomycin D largely inhibited this 
increased RNA synthesis, but the specific activity of the RNA from 
vitamin D treated animals was still greater than that of the controls. 
Vitamin D treatment was found to stimulate the incorporation of 
3 H-uridine into both RNA which could be extracted at 45°c, which is 
believed to be a mixture of cytoplasmic and nucleolar RNAs, and RNA 
extracted at 65°c. The RNA extractable at 65°c is thought to be nucleo-
plasmic RNA with a base ratio similar to that of DNA, and is possibly 
a precursor to messenger RNA. In other tissues synthesis of the 4s0 c 
RNA. has been shown to be inhibited by actinomycin D while the synthesis 
was found that actinomycin D did not inhibit the vitamin D stimulated 
increase in incorporation of 3H-uridine into either of these fractions 
of bone cell RNA. 
Vitamin D appears to increase the synthesis of all types of bone 
cell RNA. The vitamin D stimulated synthesis of cytoplasmic RNA could 
be largely blocked by pretreatment with actinomycin D, but the vitamin D 
stimulated synthesis of nucleolar and nucleoplasmic RNA was unaffected 
by actinomycin D treatment. It appears from these experiments that one 
effect of vitamin D is the stimulation of RNA synthesis in bone cells, 
/ 
but the importance of this increased RNA synthesis in the mode of action 
of the vitamin is not yet clear. 
LIFE 
Sue Ann Eckhardt Shelley we1.s born in Moweaqua, Illinois, on 
December 30, 1938. 
She graduated from Moweaqua High School, Moweaqua, Illinois in 
June, 1956, and received a Bachelor of Arts degree from Millikin 
University, Decatur, Illinois, in June, 1959. 
After five years as a Research Assistant in the Plant Virus 
Laboratory, Department of Botany, University of Illinois, Urbana, Illinois, 
and a year and one-half in the Department of Pathology at the University 
of Chicago, Chicago, Illinois, she joined the Department of Pathology, 
Loyola University Stritch School of Medicine in September, 1966. From 
that time and continuing to the present date, she has served as a 
Senior Research Assistant in that department. 
In January, 1969, she began graduate study in the Department of 
Biochemistry and Biophysics, Loyola University Stritch School of Medicine. 
On February 12, 1961, she married William E. Shelley. 
/ 
ACKNOWLEDGEMENTS 
The author is indebted to Dr. Maurice v. L'Heureux for his inspiring 
guidance throughout this research and in the preparation of this thesis, 
and to the other staff members and students of both the Department of 
Biochemistry and-Biophysics and the Department of Pathology who have 
contributed to the author's work by the exchange of ideas. 
/ 
TABLE OF CONTENTS 
CHAPTER ~ 
I · INI'RODUCTI ON • •••. • ••••••••••••••••••••••••••••••••••••••••.•• • 1 
• 
Statement of the Problem ••••••••••••••••••••••••••••••••••• 10 
II MATERIALS AND METHODS •.•••••••••••••••••••••••••••••••••••• 13 
General Experimental Design •••••••••••••••••••••••••••••••• 13 
Animal Maintenance ......••••••••••••...•.•.•.•••.••..•••••. 14 
Determination of Serum Alkaline Phosphatase •••••••••••••••• 15 
Treatment with Vitamin D and Actinomycin D ••••••••••••••••• 19 
Incubation of Bone Fragments with 3H-Uridine ••••••••••••••• 19 
!~~!~ti~~~= E~nc ~~!l~ .................................... ~! 
Extraction of RNA .•..•..••.••....•.•••••.••••.....•..••••.• 22 
Phenol· Fractionation of RNA •••••••••••••••••••••••••••• ·• ~~··.24 
Liquid Scintillation Counting •••••••••••••••••••••••••••••• 25 
III EXPERIMENTAL RESULTS ••••.•••••••••••••••••••••••••••••••••• 27 
Serum Alkaline Phosphatase Activity in Normal and 
Rachi tic Rats ........ ........•...•••.•••..... • .......•.•.. . 27 
Bone Cell Preparations ..........••.......•......... , ..•.••... 27 
RNA from Bone Cells ...•.•••••.•••.••.••••..••..•..•••.••••• 31 
Effect of Vitamin D on the Incorporation of 
3H-Uridine into Bone Cell RNA in vitro ••••• ~ ••••••••••••••• 31 
Effect of Actino~cin D on the Vitamin D Stimulated 
_Incorporation of H-Ur.idine into Bone Cell RNA _i_n _vi_t_-r_o •••• 37 
,, 
Effect of Vitamin D on the Incorporation of 3H-Uridine 
into Bone Cell RNAs Extracted at 45 C and 65°c~ •••••••••••• 37 
Effect of Actinom3cin D on the Vitamin D Stimulated 
Incorporation of H-Uridine into Bone Cell RNAs 
Extracted at 45°c and 65°c •.•••.••••••••••••••••••••••••••• 39 
IV DISCUSSION AND CONCLUSIONS ••••••••••••••••••••••••••••••••• 42 
BIBLIOGRAPHY ..•••••..•..••••..••••.••..••....•.•.•.•••••••• 46 
/ 
j . 
LIST OF TABLES 
TABLE 
I Standard Curve Data for Determination of 
Serum Alkaline Phosphatase •••••••••••••••••••••••••••••• 17 
II Serum Alkaline> Phosphatase Act:ivi ty of Normal 
and Rachi tic Rats ............••..••••...........•..••••.. 28 
III Effect of Vitamin D on the Incorporation of 3H-Uridine into Bone Cell RNA in vitro •••••••••••••••••• 36 
IV Effect of Actinomcyin D on the Vitamin D 
Stimulated Incorporation of 3H-Uridine into 
Bone Cell RNA in vitro .•...••••••.•..•...••.. ~ ..••.••••• 38 
V ~ffect of Vitamin D on the Incorporation of 
H-Uridine into Bone Cell RNAs Extracted at 0 . 
45°c and 65 C .. ~·······························•········40 
VI Effect of Actinomycin D on the Vitamin D 
Stimulated Incorporation of 3H-Uridine into 
0 0 Bone Cell RNAs Extracted at 45 C and 65 C ••••••••••••••• 41 
/ 
P-
--------------------------------------------------------------...., 
LIST OF FIGURES 
FIGURE 
1 Standard Curve for Determination of Serum 
Alkaline PhOsphatase ..•..•..•...•....•..••.•.••••••••••• 18 
2 3H-Uridine Quench Curve •••••••••••••••••••••••• • •••••••• ,26 
3 Isolated Bone Cells ...•...••••.••••••.•....••••••••••••• 29 
4 Bone Marrow Cells ....•.••.•.•.•••••••••.....•••••••••••• 30 
5 Separation of RNA from Phenol on a Sephadex G-25 
Column ••.••.••.••..•......•••••••.•••.•....••••..•••••.• 32 
6 Separation of DNA and Nucleotides after DNase 
Digestion, on a Sephadex G-25 Column •••••••••••••••••••• 33 
7 Spectra of Bone C:ell RNA and "PnrifiP.c'I YP.::tSt RNA .......... '!\4 
/ 
, 
1 
CHAPTER I 
INTRODUCTION 
Vitamin D plays an essential role in the absorption of calcium from 
the small intestine and in the mobilization of mineral from bone •. By 
these actions it functions to elevate calcium and phosphate levels in the 
serum, which are necessary for normal bone mineralization. The primary 
end effect of vitamin D is, therefore, calcification of bone, although a 
direct effect of the vitamin on the calcification process has not yet 
been demonstrated. A deficiency of vitamin D then results in defective 
calcification of bone. In young animals, the deficiency disease is 
rickets, and in adults, this failure of calcification gives rise to 
osteoid seams which are characteristic of the condition known as osteo-
1 • 
u1Ci.i.cu .. i.a. 
An important characteristic of vitamin D action is the lag time 
after administration of vitamin D to a deficient animal before any 
physiological response is noted. The length of the lag time is from 
4 to 24 hour.s depending on the dosage and the mode of administration. 
The events that occur during this time are currently under intensive 
investigation. Important discoveriei;; in recent years that have partially 
answered the question of what happens during this time period are the 
isolation and characterization of biologically active metabolites of 
vitamin D. / 
Metabolites of vita,min D first isolated were soon identified as 
esters of vitamin D and long chain fatty acids (Fraser and Kodicek, 1965), 
but these now appear to be of minor functional importance (DeLuca, 1967). 
r': 
''· --------------------------------------
2 
Another metabolite, more polar than vitamin n3 (cholecalciferol) 
proved to be of major interest. This metabolite, when given to rachitic 
animals, was more effective in the cure of rickets than the parent 
vitamin (Blunt et al., 1968b). It also stimulated intestinal calcium 
transport and bone mineral mobilization more rapidly than did vitamin n3 
(Morii et al., 1967). This active metabolite, isolated from plaiJma, by 
silicic acid column chromatography, has been identified as 25-hydroxy-
cholecalciferol (25-HCC) (Blunt et al., 1968a). Also, 25-HCC has been 
chemically synthesized and shown to be identical to the isolated material 
(Blunt and DeLuca, 1969). The corresponding metabolite from vitamin n2 
(ergocalciferol) has also been isolated and identified as 25-hydroxy-, · 
ergocalciferol (Suda et al., 1969). In addition, dihydrotachysterol3 , 
a compound structurally related to vitamin D3 and with some 'b1o1og:i:cal 
activity like vitamin D, has been shown to be converted to 25-hydroxy-
dihydrotachysterol3 in vivo (Hallick and DeLuca, 1971). 
Evidence that vitamin D must be hydroxylated at carbon 25 before it 
is effective was obj:ained in isolated end-organ experiments. Using an 
intestinal perfusion system in which calcium transport can be studied, 
Olson and DeLuca (1969) reported that direct infusion of as much as 
250 µg of vitamin n3 into the mesenteric artery of vitamin D deficient 
animals had little or no effect on calcium transport. On the other hand, 
when 0.25 µg of 25-HCC/was infosed, calcium transport rose to normal 
levels in about 1.5 hours. Other evidence that 25-hydroxylation is 
necessary for biological activity comes from studies of mineral 
mobilization in fetal bone cultures. Trununel et al., (1969} demonstrated 
~ ------------------------------------------------------------------------~ 
that as little as 0.9 International Units (I.U.) of 25-HCC per ml of 
culture media induced release of previously incorporated calcium-45 
from fetal rat bone, while as much as 400 I.U. per ml of vitamin n3 
was without effect. These results provide strong evidence that 25-
hydroxylation of the vitamin D molecule is essential for its activity. 
3 
It is also evident from the above data that both intestine and bone 
lack the ability to convert vitamin n3 to 25-HCC. The liver has been 
indicated as the major, if not sole, site of the 25-hydroxylation of 
vitamin n3 by experiments dealing with the disappearance of radioactivity 
from the plasma after 3H-vitamin n3 injection and the appearance.of 
25-HCC in the plasma (Ponchon and DeLuca, 1969). Total hepatectomy 
resulted in the toal loss of ability for the formation of 25-HCC 
(Ponchon et al., 1969}. I!~t!-: p::rfused liver and liver homogenates are 
able to form 25-HCC in vitro (Horsting and DeLuca, 1969). 
That 25-HCC is the major form of the vitamin circulating in the 
blood has been shown fo~ man as well as for experimental animals (Mawer 
et al., 1969). However, recently Cousins et al., (1970) have demonstrated 
that 25-HCC is metabolized very rapidly to metabolites more polar than 
25-HCC. Previous work by Haussler et al., (1968) and Lawson et al., (1969b) 
had already indicated the presence of a metabolite more polar than 25-HCC 
in the nuclei of intes·tinal mucosal cells. This metabolite was also 
detected in liver, kidney, bone and blood (Lawson et al., 1969c). In 
/ 
the intestine, which contains the highest quantity of this metabolite, 
the concentration is very low, and it has been found never to be above 
1 ng/g tissue. This metabolite, tentatively identified as 1,25-dihydroxy-
4 
cholecalciferol, is the predominant form of the vitamin found in the 
intestine after a physiological dose of vitamin D3 (Kodicek et al., 1970). 
The biological activity of this metabolite has been reported to be at 
least twice that of 25-HCC in stimulating intestinal calcium transport 
(Kodicek et al., 1970; Myrtle and Norman, 1971)~ Myrtle and Norman (1971) 
also report that this polar intestinal metabolite greatly shortens the 
lag time for maximum calcium transport as compared to 25-HCC. Omdahl 
et al., (1971) also report that this metabolite is very active in 
stimulating calcium absorption, demonstrating a shorter lag time than 
25-HCC. However, they found that this metabolite, while demonstrating 
nearly equivalent bone mobilization activity, had less than one-half of 
the antirachitic activity of 25-HCC. 
1''raser and Kociicek (i..;/Oj i1tsvc iJt:a1LiGed th.:. site cf hiosynthesis 
of 1,25-dihydroxycholecalciferol to be the kidney. They found that the 
intestine, liver, adrenals, parathyroid, thyroid, thymus, bone, erythro-
cytes and blood plasma all failed to convert 25-HCC to the "I-oxygenated 
25-HCC". DeLuca (1971) has reported that his laboratory has confirmed 
the finding that this intestinally-active metabolite is generated 
.... 
exclusively in kidney tissue. 
Another metabolite of vitamin n3 has been isolated from plasma and 
identified as 21,25-dihydroxycholecalciferol. This metabolite is one-
half as active as vit"lmin n3 in rats in the cure of rickets and in 
intestinal calcium transport, but is more active in the mobilization 
of bone,mineral (Suda et al., 1970). The site of synthesis of this 
metabolite which is preferentially active on bone bas not yet been found. 
F:--------------~ ~": 
5 
At present, it is not possible to state conclusiveiy what form of 
vitamin D is the form active at the target tissues. Hydro~ylation at 
carbon 25 has been shown to be necessary for activity, but whether 25-HCC 
is active· in the target tissues or whether it must be further metabolized 
is not yet clear. It is possible that both25-HCC and more polar 
metabolite"&· may,cbe 0 act:i~at the target tis.sues• 
The way in which vitamin D metabolites act at a cellular leVftl,~o 
regulate calcium transport has been suggested to involve interac~i~ 
with the genetic material of the cell stimulating RNA and subsequ,..~ly 
protein synthesis. .Several lines of evidence support this mode\ ... ef,;; 
vitamin D action. 
Stohs et aL, (1~67) have, shown that administration of vU;·f,.~;J~3 
to rachitic rats stimu,l.ates two or threefold the incorporation Q~'" 
3H-orotic acid into the RNA of the intestinal mucosa. This effett;i·t 
·-- ~·---···-··-- -· -
occurred within 3 hours after vitamin D3 administration and was1•~ttcially 
noted in the nuclear RNA. Izzo (1970) reported that vitamin D a1•t1; 
increased the incorporation of 3H-orotic acid and 3H-uridine into.,\\Qne. 
RNA., with some increase after 3 hours al:ld a maximal response·. 9 h•u:.;,a. 
after administration of vitamin n3 • A careful study of the effe¢t 
of vitamin D3 on nuclear metabolism in chick intestinal. nuclei bJ 
Lawson et al., (1969a) revealed that the proportions of RNA,.·DNA·and 
protein of the isolated' nuclei were unaffected by the vi,tamin D status 
of the animals. 3 However, the incorporation of H-orotie acid into the 
intestinal nuclear RNA was increased in vitamin D deficient chicks 
only 10 minutes after.a 125 µg d9se of vitamin n3 • Also, they reported 
~-------------. 
6 
that there ~as no st:i-)ation of DNA-dependent RNA polymerase activity 
.. of the isolated nuclei from chicks treated with vitamin n3 • These 
results suggest that since vitamin D does not cause an increase in RNA 
polymerase activity, it must affect the other factor of the RNA 
polymerase system, namely the chromatin. 
The polar metabolite, which now appears to be 1,25-dihydroxychole-
calciferol, has been shown to be selectively localized within th; nuclei 
of the intestinal mucosa cells (Haussler and Norman, 1967; Haussf~r" ~t al., 
1968). Lawson et al., (1969c) reported that 
.•• ;' i, :l ;., 
isolated chromatin from 
. · r,t f,,:,~'X( ~ 
i·ntestinal mucosa cells contained 50% of the radioactivity 16 hours after 
injection of radioactively labeled vitamin n3 • It has been sh~:'b;. 
' ,', ".'~ -~ 1-. _1 1.: . 
Hallick and DeLuca (1969) more directly that vitamin D increases the 
: I :; :' 'j 
template activity of chromatin fr0m rat intestine. In these experiments 
.· '" , 'f;"\';- <, ::.: 
chromatin, isolated from vitamin D deficient rat intestine and frQIB 
.··~'; .,_. '.)·-; . : '•. 
intestine from rats given vitamin D at various times prior to killing, 
was incubated with highly purified !· coli RNA polymerase and nucleoside 
~riphosphates ·containing 14c-ATP in an appropriate medium. Incorporation 
of 14c-ATP into the RNA during incubation was a measure of the template 
activity of the chromatin. In these experiments a very definite stimu• 
lation in template activity following vitamin D treatment was demonstrated. 
These results support the concept that vitamin D unmasks s~cific genes 
/ 
which are then available for transcription by RNA polymerase. The 
messenger RNA thus produced could code for functional pto.teins involved 
·in calcium metabolism. 
~-· _____ _, 
7 
Two such proteins have been identified in the intestine which may 
take part in the active transport of calcium. Wasserman and his 
colleagues have discovered, isolated and characterized a calciutn:""binding 
protein from chick intestinal mucosa which appears following vitaminD 
administration (Wasserman and Taylor, 1966; 1968; Wasserman et al., 1968). 
This protein has a high. affinity for calcium and appears to be'correlated 
with many aspects of intestinal calcium transport (Taylor and"Wasserman, 
1969). Another protein, a calcium-dependent adenosine triphoS'pltatase 
has been demonstrated in the brush border isolated from the int~ine of 
rats and chicks given vitamin D (Martin et al., 1969; Melancon and DeLuca, 
1970). Enzymatic activity is minimal or absent in animals deftc!"'-ent. in 
vitamin D, and there is a correlation between the time of appeS:isnce of' 
the calcium-dependent ATPase and ca:lcium transport. The inter'l'i!ll4ffonship 
between these proteins is not known, but it is possible that bothl&yitems 
operate in calcium transport in the intestine or that the calcium•stimulated 
ATPase may be associated in some way with the action of the cald.Q:n;.bi'.ndihg 
protein. v~J · · 
No such proteins have been found in bone where vitamin D abfo· ·. ' 
plays a role in calcium metabolism. In fact, Taylor and Wasse'rlllan: (1969) 
have been unable to find a calcium~binding protein in bone. They 
report that if it is present it must be at a concentration of less than 
10 µ,g/g of bone cells on a dry weight basis, which is abOU:t 200 times 
less than that found in the intestinal mucosa of vitamin D treated 
rachitic chicks. Recently, Canas· et al.., (1969) have demonstrated that 
one of the early effects of vitamin D on bone in rachitic chicks is the 
r·-·---------.. 
8 
stimulation of bone collagen synthesis, which would provide new matrix 
for the deposition of mineral. This stimulatory action of the vitamin 
appeared to be somewhat specific for bone, because collagen synthesis in 
the skin of the same animal was unaffected. 
1.'he. effect of actinomycin D, an inhibitor of DNA-directed RNA 
synthesis, on the actions of vitamin D is a subject of particular 
interest in attempting to understand the mode of action of vit~min D. 
Eisenstein and Passavoy (1964) first reported that the hypercalcemic 
response to large doses of vitamin D was blocked by actinomycin D. 
That actinomycin D blocks both the rise in serum calcium normally 
induced·by vitamin D and the increased transport of calcium by the 
intestine was shown by Zull et al., (1965) and Norman (1965). Actinomycin 
D given aftc:- vitatnin D adtuinistrat.i.0;;1 dfd nol block th* effect. of the 
vitamin, suggesting tha.t it inhibits some very early event necessary for 
- -· - - _ .. _ . 
the expression of the physiological action of vitamin D. Stohs et al., 
(1967) fot,J.nd that actinomycin D completely blocked the vitamin D stimulated· 
increase in RNA synthesis in intestinal mucosa. In the intestinal perfusion 
system describ.ed by Olson and DeLuca (1969), actinom}1cin D administered 
to the animal prior to 25-HCC blocked the rise in calcium transport but. 
actinomycin D given after 25-HCC had no effect (DeLuca, 1969). Izzo, 
(1970), however, found that the stimulatory action of vitamin D on RNA 
synthesis in bone could_,not be completely blocked by pretreatment with 
actinomycin D. 
Actinomycin D is known to block DNA-dependent RNA synthesis by 
binding to the do.uble .stranded DNA. · Actinomycin D interacts with a 
~ 
--------------------------------------------------~ 
9 
guanosine-cytosine nucleotide pair by intercalating its chromophore 
between two adjacent base pairs in the DNA (Muller and Crothers, 1968). 
However, little is known about the mechanism of binding of actinomycin D 
to the cell nucleus in vivo. Ringertz and Bolund (1969) found that 
-~
preparations of deoxyribonucleoprotein bound only one molecule of 
actinomycin per 35-140 nucleotides whereas DNA preparations bound' 
1 actinomycin D per 14-20 nucleotides. The binding of actinomycin D 
to DNA in the chromatin of different eucarocytes showed properties 
similar to the binding to DNA, but this binding was restricted by the 
chromosemal proteins. 
Low doses of actinomycin D have been shown to effectively suppress 
the formation of nucleolar and cytoplasmic RNAs, while leaving the 
synthesis o:t other nuclear RNAs relatively unaffected (Perry, 196.3) • 
• ' ; ~ ; < 
Penman et al., (1968) have also studied this heterogeneous nucleoplasmic 
RNA, whose synthesis is relatively unaffected by doses of actin~cin D 
',','J: 
which completely inhibit synthesis of ribosomal RNA. This RNA has a 
unique base c~position of 45 moles % guanine plus cytidine, res~mbling 
', '·' 
that of DNA, as compared with ribosomal RNA's 70 moles % guanine plus 
cytidine. This DNA-like RNA has been separated from other RNAs by 
successive phenol extractions at increasing temperatures (Georgiev 
et al., 1963). Treatment at 25°c yields cytoplasmic RNA.wpich includes 
transfer RNA and ribosDinal RNA. 
0 .:• . ,. 
Treatment at 45 C yields nucleolar RNA 
which is believed to be the newly formed ribosomal RNA. Extraction at 
6S0 c yields nucleoplasmic RNA, a heterogenous DNA-like RNA, which may be 
a precursor to tnRNA. This 65°c RNA fraction has been shown to have a 
much greater template activity in a cell free system than the other 
RNA fractions (Mach an:d Vassalli, 1965), but whether a small portion or 
any of it is truly messenger RNA has yet to be shown. 
An understanding of how actinomycin D blocks vitamin D action is 
important in determining the actions of vitamin.D at the cellular level. 
The failure of actinomycin D to completely inhibit the vitamin, n .. 
stimulated increase in RNA synthesis in bone might reflect a relatively 
larger increase in the synthesis of this heterogeneous nucleoplasmic 
RNA in bone cells in response to vitamin D\treatment than in the intestine. 
STATEMENI' OF .'!'..!!§. PROBLEM 
The end effect of vitamin D ts the calcification of bone, ,bu.tr-lll:ttle 
is known about the direct action of the vitamin on bone. Most:' •udt.es 
on vitamin D act:l.on have focused on its role in the intestinal:, absorption 
of dietary cah:iw. For ~ny years it was widely accepted that, thi• 
action was the sole basis for the antirachitic action of vitamin J). 
The stimulation of bone mineral mobilization by large doses of vitamin D 
was well known but was generally assumed to represent a toxic rather 
t~an a physiologic action of the vitamin. Carlsson (1952) provicted 
indirect evidence that low doses of vitamin D can enhance the ~nt 
of calcium from skeletal tissue to blood by stimulating bone;res'.Orption. 
This has been confirmed by the findi~gs of Blunt et al, (1968b.) who 
/ 
showed that both vitamin n3 and 25-HC:C cause an increase in. the serum 
calcium of vitamin D deficient rats on a calcium-free diet. ·There is 
now general agreement that vitamin I> plays a role in the physiologic 
rr-· ------------il 
t· i 
~? .. 
r· 
~ .. 
regulation of bone resorption, but little is known about how the 
vitamin acts on bone cells to cause this response. 
Parathyroid hormone (PTH) is also an important factor in stimulating 
bone resorption. Steinberg and Nichols (1968) found a very 'early 
stimulation by PTH of DNA-directed RNA synthesis in at least some bone 
cells. Owen and Bingham (1968) using autoradiography, found that PTH 
stimulated RNA synthesis in osteoclasts and inhibited RNA synthe$:f.S in 
osteoblasts. Raisz (1970) has reported that after a few hours of. 
exposure to 25-HCC or PTH, ·either singly or together, bone cultures 
begin to show resorption and this process continues even when the' .,. 
agents are removed. Actinomycin D, when present during or immediately 
after the treatment with 25-HCC or PTH, abolishes the bone resorption 
response, but actinomycin D did not completely block the response when 
given two hours after 25-HCC or PTH. This indicates that an actinomycin 
D sensitive step, which is presumably RNA synthesis, is involved in. the 
induction of the resorptive response. 
Izzo (1970) using an in~ system found that vitaminD3 stimulated 
the incorporation of RNA precursors into bone RNA. Whether this increase 
in RNA synthesis is related to bone resorption or in some way to the 
calcification process is not known. However, he found that pretreatment 
with actinomycin D could not completely block the vitamin D stimulated 
/ 
increase in RNA synthesis. Since the synthesis of some nuclear RNAs 
are known to be insensitive to inhibition by actinomycin D, it appeared 
possible that vitamin D was selectively stimulating the incorporation 
3 3 . l. ----o .. f-·H·--o_r_o_t_i_c_a_c_i_d_a_n_d_..,H_·_u_r_i_d_i_n_e_i_n_t_o_t_h_e_s_e..,· .. n·u·c-le_a.._r_R_NA_. s_,_w_h_i_c_h_a_r_e ___ ..,. 
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postulated to be precursors of messenger RNA. This messenger RNA could 
conceivably code for some protein or proteins necessary for increased 
calcium mobilization, or possibly for some protein such as collagen, 
necessary for calcification of new bone. 
The purpose of this research is to investigate the effect of 
vitamin D on the ,synthesis of various types'of RNA in bone cells and to 
determine the effect of .Pretreatment with actinomycin D. An ,!!! ~itro 
system will be used to permit isolation of RNA with a higher specific 
activity than that obtained by Izzo (1970), but will still allow 
suffieient time for vitamin D3 to be metabolized to its active form 
in the intact animal. 
/ 
13 
CHAPTER II 
MATERIALS AND METHODS 
GENERAL EXPERIMENTAL DESIGN 
Rachitic rats were obtained by maintaining 50-60 gram Holtzman rats 
on a vitamin D deficient diet for 4 to 5 weeks. Reduced growth and 
increased serum alkaline phosphatase levels were used as paramet•rs to 
determine that the rats were rachitic. 
The rats were divided into two groups; in one group each rat 
received an injection of 5,000 I.U. of vitamin n3 , and each rat in the 
•, .:._ ·, . ; '. 'r', ~- ' 
other group received an injf;'ction of the vehicle only. .In some experi-
.. ~~i .. i ·1: -~. . 
ments, each rat received an injection of 100 µg of actinomcyin l) twO 
.... tt~'1 '. ·, . 
hn,1rs pri O'!:' ti, trea t!t!ent wit!"! "!i tamin D or the vehicle. Five·~s·. 
~ r~i:.~:(t·f. · 
after the administration of the vitamin or vehicle the rats were 
\th~t$~ 
sacrificed and the humeri, tibias and femurs removed. Fragments of-
trabecular bone were dissected out, washed and incubated in Kreba"".Jinger 
bicarbonate buffer containing l µCi/ml of 3H-uridine at 37°c in an· 
•. 'f 
atmosphere of 5% C02 and 95% o2 for 4 hours. After incubation·ttMtllJone 
fragments were washed repeatedly and the bone cells isolated. 
In some experiments RNA was extracted from the bone celi~ ~-·, the 
specific activity of the RNA was.determined to see if vit.aurl.~ 1lt 111''timulated 
the incorporation of 3H;-uridine into RNA in this ~ vitl'.O &y:a:*1&. The 
RNA was extracted from the bone cell pellets with phertol•sdi.f:f'U*' dodecyl 
sulfate (SDS). The RNA was precipitated from solution With' sOdtum chloride 
and ethanol at -20°c for 16 hours and collected by ceittrf'fugadori at 
. 14 
12,000 g for 20 minutes. After treatment with DNase, residual protein was 
removed by extraction with phenol-SDS, and precipitating and centrifuging 
as above. A Sephadex G-25 column was used to free the RNA from the phenol 
and DNA nucleotides. The RNA was then precipitated and centrifuged and 
the final precipitate dissolved in a small volume of sodium acetate buffer 
for spectrophototmetric rueasurement and for scintillation counting; A 
comparison of the specific activities of the treated and control samples 
was made to determine whether or not vitamin D enhanced the incorporation 
of 3H-uridine into bone cell RNA. 
In other experiments, the RNA was separated into two fractions by 
sequential trea~ment with phenol and SDS at 45°c and 65aC. Each fraction 
of RNA was purified and concentrated as above. The specific activities 
.-· 
of the RNA fractions from treated and control animals were compared to 
determine the effect of vitamin D and actinomycin D on the synthesis of 
the various types of RNA. 
ANIMAL MAINTENANCE 
Male albino rats (Holtzman Company, Madison, Wisconsin) weighing 
50 to 60 grams were maintained in a ~thout sunlight on a vitamin D 
deficient diet with a calcium/phosphorus ratio of 5.85 (Rachitogenic Test 
Diet, U.S.P•, General Biochemicals, Chagrin Falls, Ohio). Animals fed 
a normal diet (Wayne Lab Bl ox, Allied Mills, Chicago, Illinois) served as 
/ 
.controls. A total of twenty control rats, used at various times over a 
period of about one year, ranged in weight from 230 to 270 grams after 
maintenance for four weeks on the normal diet• One hundred thirty-four 
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rats fed the vitamin D deficient diet, used as various times over the same 
period of one year, ranged in weight from 70 to 90 grams. 
DETERMINATION OF SERUM ALKALINE PHOSPHATASE 
In addition to red~ced growth, serum alkaline phosphatase levels 
were measured to confirm that the rats were rachitic. Increased serum 
alkaline phosphatase is one of the early signs of a rachitic state. 
The method used for determination of serum alkaline phosphatase is 
that of Bessey et al., (1946). Alkaline phosphatase catalyzes the 
hydrolysis of the substrate, p-nitrophenylphosphate into p-nitrophenol 
and phosphate. p-Ni trophe~ylphosphate absorbs in t.he ultraviolet region 
but not in the visible range, whereas p-nitrophenol in alkaline medium 
is yellow and has ;:i.n absorption maximum at 400 nm. .The phosphata9·e 
activity is directly proportional to the amount of p-nitrophenol liberated 
per unit time. 
Preparation of Solutions 
l• Alkaline,.buffer solution - 0.2 M Na2co3-NaHC03 buffer, pH 9.4. 
1.06 grams of Na2co3 and 3.36 grams of NaHco3 are dissolved in 
distilled water and the solution diluted to 250 ml. 
2. Substrate • p-nitrophenylphosphate 
20 mg of p-nitrophenylphosphate (Sigma Chemical Company, St. Louis, 
Missouri) is dissolved in 5 ml of distilled water and to this 
/ 
solution is added 17 5 ml of the alkaline buffer solution, pH 9 .4 • 
. 
3. Standard - p-nitrophenol, 5 !!'t! 
69.6 mg of p~nitrophenol (Sigma Chemical Company) is dissolved 
16 
in 0.02 !'! NaOH and diluted to 100.0 ml with 0.02 !'! NaOH. 
Five microliters of various dilutions of the standard solution of 
p-nitrophenol were added to 100 µl of substrate and 200 µl of 0.02 N NaOH. 
After mixing, the optical density was measured at 410 nm in the Beckman/ 
Spinco 151 Spectro-Colorimeter. This data which was used in the preparatior 
of a standard curve is shown in Table I. The linear relationship·• 
between the optical density at 410 run and the concentration of p-~itro-
phenol is shown in Figure 1. 
Serum alkaline phosphatase measurements were carried out using serum 
obtained from blood samples collected from the tail vein of the rats. 
Five microliters of serum were added to 100 µl of substrate and i~cubated 
0 
at 25 C for 30 minutes. A blank was prepared by using 5 µl of d~tii,lled 
water and a standard was prepared with each determination using 5\µl 
of 1.667 mM p-nitrophenol. 
At the end of the incubation period, the reaction was terminated 
by adding 200 ul of 0.02 !'! NaOH to each tube~ The optical density was 
measured at 410 nm in the Beckman/Spincol51 Spectro-Colorimeter. A 
correction for the yellowish color of serum was made by adding 5 µl of 
serum to 300 µl of 0.02 !'! NaOH and substracting the optical density at 
410 nm from that of the sample. 
A unit of alkaline phosphatase activity is defined as the amount of 
/ 
enzyme that will liberate 1 µm of p-nitrophenol in 1 hour: at pH 9 .4 and· 
25°c. For comparison of normal and vitamin D deficient values, the alkaline 
phosphatase activity is expressed as units per milliliter of serum. 
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TABLE I 
STANDARD CURVE DATA FOR DETERMINATION OF SERUM ALKALINE PHOSPHATASE 
µm p-Nitrophenol 
x 10-3/ml 
Number of Samples . 
2.2 4 
4.5 4 
9.1 4 
18.2 4 
27.3 4 
36.4 4 
45.4 4 
* Mean + Standard Deviation 
/ 
o.n.41o·nm* 
0.020 ± 0.005 
. 0.043 + 0.005 
0.084 ± 0~001 
0.161 + 0.009 
0.238 ± 0.016 
0.314 + 0.002 
0.398 + 0.016 
-
.. 
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FIGURE 1. Standard Curve for Determination 
of Serum Alkaline Phosphatase 
/ 
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TREATMENT WITH VITAMIN Q. ~ ACTINOMYCIN D 
Five milligrams of crystalline vitamin D3 (Mann Laboratories, 
. 
New York, New York) were dissolved in 0.5ml of 95% ethanol and then 
diluted to 10 ml with 1,2-propanediol. Five milligrams of vitamin n3 
are equivalent to 200,000 International Units: therefore, one milliliter 
of··thts:,solution'··contrd.ned::.20;000 I. U. of vitamin n3 • E•elii"ra~o:·be·· 
treated with vitamin D received an intraperitoneal injection of 0.25 ml 
of this solution containing 5,000 I. U. of vitamin n3 • 
The control animals were injected with 0.25 ml of the vehicle. 
This solution was prepared by mixing 0.5 ml of 95% ethanol and 9.5 ml 
of 1,2-propanediol. 
A solution of act:inomycin D was prepared by dissolving •c.djlbmycin D 
(Calbiochem, tos Angeles, California) to a concentration of 2off·i 14/ml in 
0.9'% saline. E.ach rat to be treated with actinomycin D recetvea an 
intraperitoneal injection of 100 µg (0.5 ml) of thiS solution. 
In each experiment, equal numbers of rachitic rats were injected 
with vitamin D and With the vehicle. The rats were injected at 20 
minute intervals so that each animal could be sacrificed and the bone 
samples prepared for incubation exactly 5 hours after injection. In 
some experiments actinomycin D was injected 2 hours prior to the 
treatment with vitamin D or vehicle. 
/ 
INCUBATION Qf. BONE FRAGMENTS !il!!! 3H-URIDINE 
Five hours after treatment with vitamin n3 or vehicle the animals 
were sacrificed by decapitation. The humeri, tibias and femurs· were 
. 20 
quickly removed and placed in cold Krebs-Ringer bicarbonate buffer . 
solution. After all the bones from one rat were collected, each bone 
was freed from extraneous tissue and split longitudinally. The bone 
marrow was washed out with pressure by using a syringe containing 
Krebs-Ringer bicarbonate buffer solution and a 25 gauge needle·. Small 
pieces· of trabecular bona were dissected out and washed again.. The., 
cleaned bone fragments had a slight creamy color, but no visible 
evidence of bone marrow contamination. 
The bone fragments from each rat were placed in a small vial 
containing 2.5 ml of the incubation medium and loosely covered with 
aluminum foil. The samples were incubated iri. a shaking water bath at 
0 
37 C in an atmosphere of 5% C02 and 95% 02 for four hours. At the end 
of the incubation period t'he samples were chilled in an ice bath and the 
medium inunediately removed. The bone fragments were then washed 4 times 
with cold Krebs-Ringer bicarbonate buffer and 4 times with cold 
phosphate-buffered saline (PBS) and kept.in cold PBS until all samples 
in an experimental group were collected. 
Preparation £f Solutions 
1. Krebs-Ringer bicarbonate buffer with p mM glucose, pH 7.4 
1000 ml of 0.90% NaCl 
40 ml of 1.15% KCl 
/ 
30 ml of 1.22% Cacl2 
10 ml of 2.11% I<HiP04 
10 ml of 3.82% MgS04•7H20 
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The above solutions are mixed and to this mixture is added 
210 ml of 1.30% NaHC03 and 2.58 grams of glucose~ Five percent 
COz is bubbled through the solution for 10 minutes to obtain a 
. pH of 7 .4. The buffer solution is stored in glass s·topi>ered 
bottles in the cold. 
2. Incuuation;:me4ium. '· 
3 . 
H-uridine (Uridine-5-T) with a specific activity :di· 24.9· Ci/mM 
(Amersham/Searle, DesPlaines, Illinois) was obtained at a 
concentration of l mCi/ml. A stock solution of 100 µ.Ci/ml 
was prepared by diluting 1.0 ml of the 3H-uridirie to 10.0 ml 
with distilled water.. Incubation media was made by diluting 
1.0 ml of the stock solution of .3H-uridine to 100.0 ml of 
Krebs-Ringer bicarbonate buffer, giving a concentration of 
1 µCi/ml of 3H-uridine. 
3. Phosphate buffered saline (PBS) 
A solution of 2. 90 g/l of Na2HP04 •7H20 in 0 .15 M NaCl and a 
solution of O. 768 g/l of NaH2Po4 ·u2o in 0.15 M NaCl were mixed 
in proportions to give a pH of 7.4. 
ISOLATION OF BONE CELLS ....._......_. ______ - - ...._ .......... _ 
The method employed for the isolation of bone cells is based on the 
procedure described by Nichols et al., (1965). The bone fragments from 
/ 
6 to 12 animals on a like treatment were pooled and transferred to a 
cold mortar~ The bone fragments were ground by hand for 3 minutes with 
about 10 ml of a soluti.on of PBS containing 0.0673 grams of calcium chloride 
. {CaCl2 ·2H20) pfa'r: ,l.00 .ml o,LPBS. The liquid wa~,. then trana £erred to conical . 
22 
centrifuge tubes. The grinding of the residue was repeated 2 more times, 
adding the liquid to the previously collected solution. This solution 
was then allowed to stand in the conical tubes in the cold for 20 minutes. 
The calcified matrix material settles to the bottom of the tube and the 
cells remain in solution. The supernatant was carefully removed, placed 
: " ., -.~,, . :. -.. 
in other, tubes, and.bone cells were·collected in a pellet·bf·~~i'i~4agQni•"i · 
at 750 g for 10 minutes (Sorvall, Refrigerated Model RCB-2, with SS-1 
0 
Rotor). The bone cell pellets were kept frozen at -20 C until extraction 
of RNA. • 
To confirm that we were isolating bone cells and not bone marrow 
cells, both were examined by light microscopy. Bone marrow was collected 
from bones which had been split longitudinally by scooping out the bone 
marrow and collecting it in a tube containing cold PBS. The cells were 
collected by centrifugation at 750 g for 10 minutes. Both bone cell and 
bone marrow cell pellets were fixed in osmic acid ~nd embedded in' Epon. 
One micron sections were stained with toluidine blue and examined by 
light microsco~y. 
EXT,MCTION OF RNA 
The method used for extraction of RNA was the widely used phenol 
extraction method described by Kirby (1956) which depends 011 the 
part:ition o.f RNA between aqueous buffer and 88% phenol. Steinberg 
/ 
and Nichols (1967) used this method to isolate RNA from normal bone 
cells. The method outlined below is the same as that used by Steinberg 
and Nichols· except for the use of .a Sephadex G•25 column to separate 
RNA from phenol. 
The pellet of bone cells was homogenized in 9 ml of a sucrose 
medium composed of 0.25 M sucrose and 1 mM MgC12 in 10 ~ Tris-HCl 
buffer, pH 7.4, using a ground glass homogenizer. The homogenate 
was made 0.5% with respect to SDS by adding 1 ml of a 5% solution· of 
23 
SDS. After stirring for 10 minutes at room temperature, an equal volume 
0 (10 ml) of phenol was added and the sample stirred at 4 C for 30 minutes. 
Centrifugation at 12,000 g for 10 minutes was used to break the emulsion. 
The upper aqueous p~ase and the material at the interface were removed 
0 
and reextracted with 5 ml of phenol for 10 minutes at 4 C and centrifuged. 
The phenol layer obtained in the first centrifugation was reextracted 
with 10 ml of the sucrose medium for 10 minutes at 4°c and centrifuged. 
The aqueous phases from each of these two latter centrifugations were 
carefully removed and combined. 
The RNA was precipitated from solution by adding 0.1 volume of 
·o 2 !! NaCl and 2 volumes of 95% ethanol and storing overnight at -20 C 
in a freezer. The RNA was collected by centrifugation at 15, 000 g for. 
20 minutes. The precipitate was resuspended in 8 ml of 0.02 ! Mgso4 in 
0.02 M Tris-HCl buffer, pH 7.4. This solution of RNA was treated with 
deoxyribonuclease (Worthington Biochemical Corp., Freehold, New J•rsey), 
at a concentration of 10 µg/ml for 20 minutes at room temperature,tith 
stirring. The residual protein was removed by extracting again ,n.th 0.5% 
. SDS and 0.5 volume of phenol for 15 minutes at 4°c. After centdfugation 
/ 
to break the emulsion the aqueous phase was removed and the RNA was 
precipitated from solution with sodium chloride and ethanol as before. 
. . 
After 90 minutes or longer, the precipitate was collected by centrifugation.' 
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This precipitate was dissolved in l to 2 ml of distilled water 
and was passed through a Sephadex G-25 column to remove the DNA nucleo-
tides and phenol. The eluent from the column was monitored in a 
Beckman DB spectrophotometer, using a 5 nun flow cell, by observing the 
increase in optical density at 258 nm. The RNA collected from the 
column was again precipitated with sodium chloride and ethanol and the· 
final precipitate dissolved in a small volume of 0.25 M sodium acetate 
buffer, pH 5.3. 
The amount of RNA present was determined by using a standard 
yeast RNA sample (Sigma Chemical Company) and the Beck.man DB spectro-
photometer at a wavelength of 258 nm. 
PHENOL FRACTIONATION OF RNA 
RNA was extracted in the same way as described before, except 
that after stirring the bone cell homogenate-phenol-SDS mixture for . 
0 
30 minutes at 4 C, this mixture was heated and stirred for 15 minutes 
at 45°c •. After centrifugation to break the emulsion the upper phase 
was removed without disturbing the interface and the lower phase and 
interface were reextracted with sucrose media and SDS for 15 minutes 
at room temperatuTe. After centrifugation the upper phase was carefully 
removed and combined with the previous aqueous phase. The combined 
aqueous phases were reextracted with 5 ml of phenol for 15 minutes at 
/ 
room temperature. After centrifugation, the upper phase was removed 
and the RNA precipitated from solution as described in the .. previous 
section. 
r..----------------------------------------. ~ 
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Sixty-five degree RNA was extracted by adding fresh phenol to the 
interface material and homogenizing with SDS and sucrose media. After 
stirring for 10 minutes at room temperature, the sample was heated and 
0 
stirred at 65 C for 15 minutes. It was then centrifuged, reextracted 
and precipitated in the same manner as the 45°c RNA. 
Each of these samples, 45°c RNA and 65°c RNA, were then treated· 
with DNase, extracted again with phenol, separated on a Sephadex G-25 
column and the amount of RNA present determined as described in the 
previous section. 
LIQUID SCINTILLATION COUNTING 
A 0.2 or 0.5 ml aliquot of the sample of RNA was placed in· a. 
liquid scintillation counting vial and to this was added 15 ml of the 
toluene counting solution. The toluene counting solution was prepared 
by dissolving 5 grams of PPO (2,5-diphenyloxazole) in one liter of toluene. 
To every 100 ml of this solution was added 20 ml of Beckman solubilizing 
reagent Bio-Solv BBS-3. The samples were counted in the LS-250 
Liquid Scintiliation Spectrometer using the automatic quench correction. 
A quench curve was prepared by.adding various amounts of RNA isolated 
from bone cells in 0.25 M sodium acetate buffer, pH 5~3 to 15 ml of 
the toluene counting solution containing 0.1 µ.Ci of 3H-:uridine. These 
samples were counted with the LS-250 Liquid Scintillation Spectrometer 
/ 
(Beckman Instruments) using the automatic quench correction. The per cent 
efficiency was plotted against the external standard ratio (Figure 2). 
The specific activity of the RNA was expressed as disintegrations 
. per minute per milligi::am of RNA (dpm/mg RNA). 
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CHAPTER III 
EXPERIMENfAL RESULTS 
SERUM ALKALINE PHOSPHATASE ACTIVITY IN NORMAL AND RACHITIC ~ 
Serum al.kaline phosphatase measurements were made on two rats fed 
a normal diet and two or three rats fed a vitamin D deficient for 4 weeks 
selected at random from each group of animals to be used for a given 
experiment. As shown in Table II, the serum alkaline phosphatase levels 
of the vitamin D deficient rats were significantly higher than those of 
rats fed a normal diet. These results, in accord with the much lowe-.:-
body weight, show that the rats fed a vitamin D deficient diet are· 
indeed rachitic. Additionally, this conclusion was confirmed by the 
appearance of the bones when ·the rats were sacrificed. 
-
BONE CELL PREPARATI.ONS 
Since the spaces in trabecular bone are filled with bone marrow 
cells, it was necessary to determine that the cells released by grinding 
trabecular bone fragments were bone cells and not bone marrow cells. 
Bone cell pellets were a creamy white color. The absence of a grossly 
red color as one sees with bone marrow cells was one of the criteria used 
to determine that bone cells and not bone marrow cells were being isolated. 
Histological examination of bone cell and bone marrow cell preparations 
showed that although t~e bone cell pellets contained a heterogetious 
mixture of cells (Figure 3), there were very few cells typical of bone 
marrow such as red blood cells, megakaryocytes and myeloid cells (Figure 4). 
TABLE II 
SERUM ALKALINE PHOSPHATASE ACTIVITY OF NORMAL AND RACHITIC RATS 
(units/ml serum) 
Normal 
3.09 
1.75 
1.96 
2 .49 
2.74 
2.65 
2.44 
2 .46 
2.73 
2.49 
2.84 
. 2.26 
.2 .48 
2.56 
2.83 
3.05 
* 2.56 + 0.32 
/ 
* Mean ± Standard neviation. 
' .. 
* 
6~44 ;;< 
5.17 
4 •. 87 
5.78 
5.83 
4.30 
4.66 
4.16 
·. 5.19 
5.53 
5.17 
4.54 
. 5.42 
4~64 
3.95 
6.24: 
4.75 
7.30 
4.93 
5.20 ± 0.84 
. 28 
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FIGURE 3. Isola ted Bone Cells (x 600) 
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FIGURE 4. Bone Mar:row Cells (x 600). (a) megakaryocyte, (b) myeloid 
cell, (c) red blood cell. 
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It appears that this procedure results in the isolated of bone cells 
relatively uncontaminated with bone marrow cells. 
~ ~ BONE CELLS 
A typical separation of RNA from phenol on a Sephadex G-25 column 
is shown in Figure 5. To establish that.any DNA digested by DNase· 
treatment would be separated on this column, an excess of DNA {Worthington 
.. 
Biochemical Corp.) was digested with DNase and passed through the coluinn 
(Figure 6). No such peaks were observed between RNA and phenol in any 
of the experiments, indicating that little or no DNA was extracted. 
The spectrum of RNA isolated from bone cells of eleven rachitie · 
\ 
rats is shown in Figure 7 and for comparison a spectrum of purified 
in each sample in the various experiments ranged from 5 to 25 µg. The 
optical density at 258 nm was used to calculate the amount of RNA· present. 
3 . 
EFFECT OF VITAMIN D ON THE INCORPORATION OF H-URIDINE INTO BONE CELL 
- ---- ' - - ----
RNA IN VITRO 
----
Two experiments were carried out in order to determine the ef·fect 
of vitamin D3 on the incorporation of 
3H-u~idine into bone c~:~l Bi*-
using an in vitro system. In each experiment 8 rachitic rats w.e:re 
' 
injected intraperitoneally with 5,000 I.U. of vitamin D3 and 8 rachitic 
rats were injected with the vehicle only. Rats were injected at 20 minute 
intervals so that.each animal could be sacrificed and the tibias, femurs 
and humeri removed and cleaned exactly 5 hours after treatment. Bone 
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FIGURE 5. Separation of RNA from Phenol on a Sephadex 
G-25 Column. (I) RNA , (II) Phenol 
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FIGURE 6. Separation of DNA and Nucleotides after DNase 
Digestion, on a Sephadex G-25 Column . 
(I) DNA , (II) and (II I ) Fragments of DNA 
recovered after DNase treatment. 
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fragments were incubated for 4 hours with 3n-uridine and then washed 
and chilled in an ice-bath to stop the incorporation of the isotope. 
A total of 9 hours from the time of treatment with vitamin D or vehicle 
to the end of the exposure to 3n-uridine was chosen because Izzo (1970) 
found that 9 hours was. the time of maximal incorporation of precursors 
into RNA in bone using an in ~ system. 
The bone fragments from the 8 rats in each experimental group 
were pooled and bone cells isolated. RNA was extracted and measured 
as described in Chapter II. Aliquots were then used for scintillation 
counting and the specific activity expressed as disintegrations per 
minute per milligram of RNA. 
In hoth evperim~nts, t"1e sped f:I r ~rt:iir:f ty of the RNA ft'o'!TI th.,, · 
vitamin. D treated animals was greater than that of the controls (Table III). 
The ratios of the specific activity of the RNA from vitamin D treated 
rats and the specific activity of the RNA from rats treated with the 
v~hicle only (T/C ratio) were comparable to the results reported by 
.,. ' ' ''' ·?.; 
Izzo (1970) which were 1.3_6, 1.06, 1.48, 1.74 and 1.42 giving an average 
of 1.4. The specific activity of the RNA in these. experiments was about 
forty times higher than those of the in .Y!!.£ experiments by Izzo (1970). 
It can be concluded from these results that, in agreement with 
the experiments of Izzo (1970), vitamin D does enhance the incorporation 
/ 
of 3H-uridine into RNA into bone in this in vitro system. 
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TABLE III 
EFFECT OF VITA.MI~ D ON THE INCORPORATION OF 3H-URIDINE INTO BONE CELL 
RNA IN VITROa 
Experiment 
1 control 
Vitamin D 
2 Control 
Vitamin D 
Specific Activity of RNA 
(dpm/mg RNA) 
71, 708 ± 1076c 
133,248 ± 1999 
88,507 ± 1328 
117 ,962 ± 1769 
Treatedb 
Control 
1.86 
1.33 
8 Rachitic rats were sacrificed 5 hours after injection with 5,000 I.U. of 
b 
vitamin n3 or vehicle. Bone fragments were incubated for 4 hours with 
3H-uridine. RNA was extracted from bone cells isolated from these 
bone fragments. 
Ratio of the specific activity of RNA from vitamin D treated rats and 
the specific activity of RNA from rats treated with the vehicle only. 
cSpec i fie activity ± 1. 5% counting error. 
/ 
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EY:f:ZCT fil: ACTINOMYCIN Q. ON THE VITAMIN Q.. STIMULATED INCORPORATION .QK 
3H-URIDINE INTO.BONE CELL RNA IN VITRO 
- --........ _.,.... -- ---:--- - ---
The next experiment was designed to determine the effect of 
actinomycin D on the increased incorporation of 3H-uridine into bone 
cell RNA following vitamin D treatment in this in vitro system. The 
procedure was the same as outlined in the previous experiment. Each 
rat received two intraperitoneal injections of 50 µg each of actinomycin D, 
on.e 6 hours before and one 2 hours before treatment with vitamin D or 
vehicle. Each of the two experimental groups consisted of eight animals. 
The results shown in Table IV indicate that actinomycin D was 
effective in decreasing the incorporation of 3H•uridine into RNA in both 
the vitamin D treated and control animals as compared with those animals 
not treated with actinomycin D (Table III). However, the specific activity· 
of the bone cell RNA from vitamin D treated animals was still greater 
than that of the controls. 
EFFECT OF VITAMIN Q. ON THE INCORPORATION OF 3!!-URIDINE INTO BONE CELL 
RNAS EXTRACTED AT 45°C AND 65°C 
- ------.-
The synthesis of some nuclear RNAs, which are thought to be precursors 
to messenger RNA, have been shown to be unaffected by actinomycin l> 
pretreatment. These RNAs can be isolated by sequential fractionation 
with phenol-SDS. Treat~ent at 45°c should yield cytoplasmic and nu~leolar 
RNA. Following treatment at 45°c these nuclear RNAs, insensitive to 
0 
actinomycin D, can be obtained by extraction at 65 c. 
The next two experiments were designed to determine the effect of 
vitamin D on the incorporation of 3H-uridine into these two fractions of 
TABLE IV 
EFFECT OF ACTINOMYCIN D ON THE VITAMIN D STIMULATED INCORPORATION OF 
3H .. URIDINE INTO BONE CELL RNA IN VITR08 
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Specific Activity of RNA 
(dp&Qmg. ,J.lliA) 
Treatedb 
Control 
Vitamin D 
13,557 ± 407c 
22 ,816 ± 684 
· Contr.ol 
1.68 
aRachitic rats were given two intraperitoneal injections of 50 µg of 
actinomycin D 6 hours and 2 hours before an injection of 5,000 I.U. 
of vitamin D3 or vehicle. Bone fragments were incubated for 4 hours 
with 3H-uridine. RNA was extracted from bone cells isolated from 
these bone fragments. 
bRatio of the specific activity of RNA from vitamin D treated rats and 
the specific activity of RNA from rats treated with the vehicle only. 
cSpecifiC activity± 3.0% counting error. 
/ 
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RNA. Two experimental groups, each consisting of eight animals, were 
used. The experiments were carried out as previously described, but 
the. RNA was separated into two fractions as described in the chapter on 
Materials and Methods. 
The results presented in Table V show that vitamin D stimulated 
the incorporation of. 3H-uri.dine into both 45°c a~ 65°c RNA. In both 
experiments, the treated/control ratio of specific activities was 
0 0 greater for the 65 C than for the 45 C RNA.. 
EFFECT OF ACTINOMYCIN Q. QN THE VITAMIN Q. STIMULATED INCORPORATION OF 
3H-URIDINE INTO BONE CELL RNAS EXTRACTED AT 45°C AND 65°c 
- . ___ ....__..__ -----
The next experiment tested the effect of actinomycin D on the 
vitamin D stimulated incorporation of 3H-uridine into the two RNA 
fractions. The experiment was done as previously described except 
that 12 rats were used in each experimental groups and each rat received 
an intraperitonealinjection of 100 µg of actinomycin 1D two hours before 
treatment with vitamin D or vehicle. 
The results given in Table VI show that actinomycin D did not 
3 
inhibit the vitamin D stimulated incorporation of H-uridine into either 
45°c or 65°c RNA. In fact, the treated/control ratio of specific activities 
of the 45°C RNA appears to be increased by actinomycin D pretreatment. 
Vitamin D increased the incorporation of 3H-uridine into both 
/ 
fractions of bone cell RNA and this response was not inhibited by 
actinomycin D. · 
TABLE V 40 
EFFECT OF VITAMIN DON THE INCORPORATION OF 3H-URIDINE INTO BONE CELL 
RNAS EXTRACTED AT 45°c AND 65°c8 
\ 
Experiment Temperature of Specific Activity of RNA Treated b 
Extraction of RNA (dpm/mg RNA) Control 
45°C 
c 
1 Control 24,078 ± 482 
1.22 
Vitamin D 29,334 ± 587 
0 
34,473 ± 65 c Control 689 
1.45 
Vitamin D 49,902 ± 998 
2 45°c Control 56, 954 ± 1139 
1.35 
Vitamin D 76,122 ± 1534 
v ) 
65°c Control 17 ,447 ± 349 
t';i, 
'1.62 
Vitamin D 28,276 + 566 
' ' -
8 Rachitic rats were sacrificed 5 hours after injection with,~im f.~u. of 
Bone fragments were incubated for 4 hours ~th 
' :,' ~'.·~ .·~;. b. !'· '4,,f·l{;'. ~~·. vitamin o3 or vehicle. 3 . 
H-uridine. After isolation of bone cells, RNA was fracti~ted into 
0 0 
RNAs extractable at 45 C and 65 c. 
b Ratio of the specific activity of RNA from vitamin D treated rats and 
the specific activity of RNA from rats treated with the veh~cle qnly. 
/ 
c 
Specific activity± 2.0% counting error. 
TABLE VI 
EFFECT OF ACTINOMYCIN D ON THE VITAMIN D STIMULATED INCORPORATION OF 
3
H-URIDINE INrO BONE CELL RNAS EXTRACTED AT 45°c AND 65°c8 
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Temperature of 
Extraction of RNA. 
Specific Activity of RNA 
(dpm/mg RNA) 
. . b 
Treated 
Control 
Vitamin D 
Control 
Vitamin D 
c 
20,379 ± 408 
37,663±753 
33,333 ± 667 
49,583 ± 992 
Control 
1.85 
1.49 
8Rachitic rats were given 100 µg of actinomycin D intraperitoneally 
2 hours before 5,000 I.U. of vitamin D3 or vehicle. Bone fragments 
were incubated for 4 hours with 3H-uridine. After isolation of bone 
0 0 
cells, RNA was fractionated into RNAs extractable at 45 C and 65 c. 
bRatio of the specific activity of RNA from vitamin D treated rats 
and the specific activity of RNA from rats treated with the vehicle 
only. 
cspecific activity± 2.0 % counting error. 
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
Vi~~n D has been·reported to cause many metabolic changes 
including alteTations in bone citrate content (Carlsson and Hollunger, 
1954), phospholipid metabolism (Thompson and .neLuca, 1964; Neville.:,: .... 
Holdsworth,. 1968), ca2+ release by mitochondria (Engstrom and DeLuc•, 
1964} and ·adenyl cyclase activity (Neville and Holdsworth, 1969),. but 
the relation of these changes to the physiologic actions of vitamin,l),&Jie 
not known. The question that arises here is whether the increased 
incorporation of nucleic acid precursors into RNA observed.in bone under 
the stimulus of vit~n D is directly involved in the mod• of action of 
The effect of vitamin D on RNA synthesis in otheT tis,ues is of 
particular interest in respect to this work. In the .intestine, Stohs 
et al., (1967), found that after the administration to rats of a 2,000 
I.U. dose of vitamin n3 , maximal inc.oTporation of 
3H•orotic acid int'> 
nuclear RNA occurred at j hours with a T/C ratio of 2.81; however, this 
increase could be completely blocked by actinomycin D given 2 hours 
before treatment with vitamin D. Lawson et al., (1969a) found in 
chicks that 125 µ.g of vitamin n3 increased the incorporation of 
3H-orotic 
acid into nuclear RNA; jn three experiments they found T/C ratios of 1.83, 
1.13 and 5.02, one hour after intracardial injection. 
Stohs et al., (1967) also studied the effect of vitamin D on 
3u-o~otic acid i~orporation into nuclear RNA of _rat liver and kidney, 
.. 
tissues that are not known to be affected by vitamin D. They found 
T/C ratios of 1.30 for liver and L53 for kidney. These values are 
in the same range as those found for bone. 
A possible explanation for the increased RNA synthesis in kidney 
43 
can be found on the basis of a recent report by Tanaka and DeLuca (1971). 
They found' that actinomycin D administered prior to radioactive 25-HCC 
blocked the metabolism of 25-HCC to the polar metabolite(s) that accumulate 
in the intestinal tissue. The site of biosynthesis for at least one of 
these metabolites is the kidney (Fraser and Kodicek, 1970). Actinomycin D, 
however, did not prevent the 25-hydroxylation of vitamin D3 in the liver. 
There is considerable evidence that vitamin D or its metabolites 
can interact with DNA to stimulate RNA synthesis in the intestine, and 
possibly in the kidney. 'there is· also some evidence from organ cultures· 
that this interaction precedes bone resorption. The results of our 
experiments indi<:ate that vitamin n3 does increase the rate of synthesis 
of both ribosomal and nucleoplaemic RNA in bone cells. The increased 
synthesis of RNA found in our system may be related to resorption, but 
since vitamin D is needed for normal calcification in addition to the 
resorption process even in the presence of an adequate dietary supply 
of calcium and phosphorus (DeLuca, 1967), the increase co1,1ld be related 
to the calcification process. 
The synthesis of the RNA extracted at 4°c in these experiments, 
which is most likely cytoplasmic RNA, was found to be larg.ely inhibited 
by actinomycin D; however, the specific activity of the RNA from vitamin D 
treated animah was. still larger than that of the controls. The two fraction 
44 
of RNA (45°C and 65°c) obtained in these experiments showed increased 
incorporation of 3H-uridine into RNA, and this increased incorporation 
was not blocked by actinomycin D pretreatment. This indicates that 
vitamin.D stimulated the synthesis of all nuclear RNAs in bone cells 
and not spe,cifically the DNA-like nucleoplasmic RNA resistant to actino-
myciti D inhi.bition. In fact, the synthesis of RNA which can be extracted 
at 45°c, which others have found to be completely blocked by actinomycin D 
• '•j • 
(Ceorgiev• 1967), appears to be increased in animals treated with actino-
mycin D and vitamin D (T/C ratio= 1.85) over those animals not treated 
with ac~inomycin D (T/C ratio= 1.22 and 1.35). Whether these numbers 
are significant is not knowri, but it is of interest to note that Izzo 
(1970). found that in each of three experiments where .RNA ~as extracted 
at 65°c only, the Tfe ratio was higher in the animals ttea~ed with 
actinomycin D than those treated with only the vitamin (T/c· ratio 1.53 
as compared to 1.31; 1.54 to 140; and 1.49 to 1.14). 
Why actinomycin D does .not inhibit the vitamin D stimulated increase 
i.n 45° RNA synthesis is puzzling. One possibility is that the dose of 
vitamin n3 of 5,000 I.U. which is 500 times that considered physiological 
(10 I.U.) may be overcoming th~ effect of actinomycin D. Corradino and 
Wass~~an (1968): reported that While actinomycin D inhibits the formation 
i 
of vitamin D induced calcium-binding protein in the intestinal mucosa, 
this inhibition can be /overcome by large doses of vitamin D. Complete 
.. 
inhibition of formation of calcium-binding protein was achieved when 
the vitamin n3 dose was 100 I.U., but with 250 and 500 I.U. of vitamin D3 
progressively less inhibition was seen. Stohs et .al., (1967), however, 
45 
used doses of 2,000 I.U. of vitamin D3 and found that the increase in RNA 
synthesis caused by vitamin D3 in the intestine could be completely 
inhib;i.ted by actinomycin D. 
· In summary, it was found that vitamin D increased the incorporation 
3 
of H-uridine into all types of bone cell RNA. The vitamin I> stimulated 
with actinomycin D, but vitamin D stimulated synthesis of nucleolar and 
nucleoplasmic RNA remained unaffected following actinomycin D treatment. 
It appears· from these experiments that one effect of vitamin Dis the 
.stimulation of RNA synthesis in bone cells, but the importance of this 
increased RNA synthesis in the mode of action of the vitamin is not yet 
clear. 
/ 
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